Do fumonisins cause liver toxicity through oxidative stress and inflammatory injury?

Fumonisins, particularly Fumonisin B1 (FB1), are secondary metabolites produced by Fusarium fungi that frequently contaminate maize and maize-based products. These mycotoxins are recognized as potent hepatotoxins in numerous mammalian models, with toxicity characterized by significant biochemical and structural changes in liver tissue.

Clinical and pathological evidence

In animal models, including rodents and swine, exposure to FB1 results in dose-dependent liver damage. Pathological markers include vacuolar degeneration, lipid accumulation, and necroinflammation. Chronic exposure studies in mice have specifically linked fumonisin ingestion to an increased incidence of hepatocellular carcinomas. In laboratory settings, hepatotoxicity is frequently monitored through elevated serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), reflecting acute hepatocellular injury and leakage.

Mechanistic explanations

The toxicity of fumonisins is primarily driven by their structural similarity to sphingoid bases, leading to the inhibition of ceramide synthase. This disruption has cascading effects on cellular health:

• Sphingolipid Disruption: Inhibition of ceramide synthase causes an accumulation of sphinganine and sphingosine. The resulting increase in the sphinganine/sphingosine (Sa/So) ratio is a hallmark biomarker of fumonisin exposure.
• Oxidative Stress: The accumulation of free sphingoid bases triggers mitochondrial dysfunction, leading to the overproduction of reactive oxygen species (ROS) such as hydrogen peroxide ($H_2O_2$). Research indicates a significant increase in malondialdehyde (MDA), a marker of lipid peroxidation, alongside a depletion of antioxidant enzymes like superoxide dismutase (SOD).
• Inflammatory Injury: This oxidative environment activates the NF-κB signaling pathway, which upregulates pro-inflammatory cytokines and apoptotic factors. These pathways collectively lead to programmed cell death (apoptosis) and eventual fibrosis in liver tissue.

Bottom line

Fumonisins cause liver toxicity through a well-defined mechanistic sequence involving the disruption of sphingolipid metabolism, which triggers mitochondrial oxidative stress and activates pro-inflammatory pathways leading to hepatocellular damage.